NCT03117101View on ClinicalTrials.gov

Study of the AL3810 in the Treatment of Advanced Solid Tumor

PHASE1CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

September 30, 2016

Study Completion Date

September 30, 2016

Conditions
Advanced Solid Tumors
Interventions
DRUG

Lucitanib

Trial Locations (1)

200000

Fudan University Shanghai Cancer Center, Shanghai

Sponsors
All Listed Sponsors
collaborator

Shanghai Institute of Materia Medica, Chinese Academy of Sciences

OTHER

lead

Haihe Biopharma Co., Ltd.

INDUSTRY